Cefuroxim Labatec i.v. 750 mg, poudre pour solution injectable
7680614750015
Pharmacode 5011416
CH-61475
J01DC02
08.01.3.
Active substances:
1 / 3
google
Details
- GTIN
- 7680614750015
- Pharmacode
- 5011416
- Product number
- 6147501
- CPT
- -
- Packaging group
- 1 x 750
- Unit
- mg
- Composition
- Praeparatio sicca: cefuroximum 750 mg ut cefuroximum natricum corresp. natrium 40.63 mg, pro vitro.
Articles (1)
Cefuroxim Labatec i.v. 750 mg, poudre pour solution injectable
poudre pour solution injectable
1 x 750
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
cefuroximum
|
750.0 MG | Substance | Wirkstoff (Principe actif) |
|
cefuroximum natricum
|
- | Substance | WIZUS |
|
natrium
|
40.63 MG | Substance | HBESI |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 61475
- Drug name
- Cefuroxim Labatec i.v., poudre pour solution injectable/pour perfusion
- Galenic form
- PULVII
- ATC Code
- J01DC02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 06/12/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CEFUROXIM Labatec 750 mg i.v. flac
- Description (DE)
- CEFUROXIM Labatec 750 mg i.v. Durchstf
- Market launch
- 06/12/2010
- Market withdrawal
- 30/03/2026
- Narcotic (BTM)
- No